Trinity Biotech (TRIB) announced the appointment of Adrian Donohue as Chief Commercial Officer. Donohue brings more than 25 years of experience in the sales and marketing of healthcare products. Adrian developed his knowledge and early career success as a sales representative for Menarini, Eli Lilly (LLY) and Roche (RHHBY).
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRIB:
- 3 Penny Stocks to Watch Now, 8/29/24
- Trinity Biotech Files Prospectus Supplement for ADS Offering
- Trinity Biotech Raises 2024 Revenue Forecast
- Trinity Biotech announces increased orders for TrinScreen HIV
- Trinity Biotech Announces Increased Orders for TrinScreen HIV and Raises Guidance For 2024 Sales